Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy

in vitro studies

Arumugam Radhakrishnan Jayakumar, Xiao Y. Tong, Nagarajarao Shamaladevi, Stephanie Barcelona, Gabriel Gaidosh, Apeksha Agarwal, Michael D Norenberg

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Transactivating DNA-binding protein-43 (TDP-43) inclusions and the accumulation of phosphorylated and ubiquitinated tau proteins (p-tau) have been identified in postmortem brain specimens from patients with chronic traumatic encephalopathy (CTE). To examine whether these proteins contribute to the development of CTE, we utilized an in vitro trauma system known to reproduce many of the findings observed in humans and experimental animals with traumatic brain injury. Accordingly, we examined the role of TDP-43 and Tau in an in vitro model of trauma, and determined whether these proteins contribute to the defective neuronal integrity associated with CNS trauma. Single or multiple episodes of trauma to cultured neurons resulted in a time-dependent increase in cytosolic levels of phosphorylated TDP-43 (p-TDP-43). Trauma to cultured neurons also caused an increase in levels of casein kinase 1 epsilon (CK1ε), and ubiquitinated p-TDP-43, along with a decrease in importin-β (all factors known to mediate the “TDP-43 proteinopathy”). Defective neuronal integrity, as evidenced by a reduction in levels of the NR1 subunit of the NMDA receptor, and in PSD95, along with increased levels of phosphorylated tau were also observed. Additionally, increased levels of intra- and extracellular thrombospondin-1 (TSP-1) (a factor known to regulate neuronal integrity) were observed in cultured astrocytes at early stages of trauma, while at later stages decreased levels were identified. The addition of recombinant TSP-1, conditioned media from cultured astrocytes at early stages of trauma, or the CK1ε inhibitor PF4800567 hydrochloride to traumatized cultured neurons reduced levels of p-TDP-43, and reversed the trauma-induced decline in NR1 subunit of the NMDA receptor and PSD95 levels. These findings suggest that a trauma-induced increase in TDP-43 phosphorylation contributes to defective neuronal integrity, and that increasing TSP-1 levels may represent a useful therapeutic approach for the prevention of the neuronal TDP-43 proteinopathy associated with CTE. (Figure presented.). Read the Editorial Highlight for this article on page 531.

Original languageEnglish (US)
Pages (from-to)645-661
Number of pages17
JournalJournal of Neurochemistry
Volume140
Issue number4
DOIs
StatePublished - Feb 1 2017

Fingerprint

Thrombospondin 1
DNA-Binding Proteins
Casein Kinase Iepsilon
Defects
Wounds and Injuries
Neurons
Brain
Astrocytes
Karyopherins
tau Proteins
Phosphorylation
Ubiquitinated Proteins
Conditioned Culture Medium
Chronic Traumatic Encephalopathy
Multiple Trauma
Animals
Proteins

Keywords

  • astrocytes
  • chronic traumatic encephalopathy
  • neurons
  • p-tau
  • TDP-43 proteinopathy
  • thrombospondin-1

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy : in vitro studies. / Jayakumar, Arumugam Radhakrishnan; Tong, Xiao Y.; Shamaladevi, Nagarajarao; Barcelona, Stephanie; Gaidosh, Gabriel; Agarwal, Apeksha; Norenberg, Michael D.

In: Journal of Neurochemistry, Vol. 140, No. 4, 01.02.2017, p. 645-661.

Research output: Contribution to journalArticle

Jayakumar, Arumugam Radhakrishnan ; Tong, Xiao Y. ; Shamaladevi, Nagarajarao ; Barcelona, Stephanie ; Gaidosh, Gabriel ; Agarwal, Apeksha ; Norenberg, Michael D. / Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy : in vitro studies. In: Journal of Neurochemistry. 2017 ; Vol. 140, No. 4. pp. 645-661.
@article{b816d4ec42c54e15a1220e92768367ca,
title = "Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies",
abstract = "Transactivating DNA-binding protein-43 (TDP-43) inclusions and the accumulation of phosphorylated and ubiquitinated tau proteins (p-tau) have been identified in postmortem brain specimens from patients with chronic traumatic encephalopathy (CTE). To examine whether these proteins contribute to the development of CTE, we utilized an in vitro trauma system known to reproduce many of the findings observed in humans and experimental animals with traumatic brain injury. Accordingly, we examined the role of TDP-43 and Tau in an in vitro model of trauma, and determined whether these proteins contribute to the defective neuronal integrity associated with CNS trauma. Single or multiple episodes of trauma to cultured neurons resulted in a time-dependent increase in cytosolic levels of phosphorylated TDP-43 (p-TDP-43). Trauma to cultured neurons also caused an increase in levels of casein kinase 1 epsilon (CK1ε), and ubiquitinated p-TDP-43, along with a decrease in importin-β (all factors known to mediate the “TDP-43 proteinopathy”). Defective neuronal integrity, as evidenced by a reduction in levels of the NR1 subunit of the NMDA receptor, and in PSD95, along with increased levels of phosphorylated tau were also observed. Additionally, increased levels of intra- and extracellular thrombospondin-1 (TSP-1) (a factor known to regulate neuronal integrity) were observed in cultured astrocytes at early stages of trauma, while at later stages decreased levels were identified. The addition of recombinant TSP-1, conditioned media from cultured astrocytes at early stages of trauma, or the CK1ε inhibitor PF4800567 hydrochloride to traumatized cultured neurons reduced levels of p-TDP-43, and reversed the trauma-induced decline in NR1 subunit of the NMDA receptor and PSD95 levels. These findings suggest that a trauma-induced increase in TDP-43 phosphorylation contributes to defective neuronal integrity, and that increasing TSP-1 levels may represent a useful therapeutic approach for the prevention of the neuronal TDP-43 proteinopathy associated with CTE. (Figure presented.). Read the Editorial Highlight for this article on page 531.",
keywords = "astrocytes, chronic traumatic encephalopathy, neurons, p-tau, TDP-43 proteinopathy, thrombospondin-1",
author = "Jayakumar, {Arumugam Radhakrishnan} and Tong, {Xiao Y.} and Nagarajarao Shamaladevi and Stephanie Barcelona and Gabriel Gaidosh and Apeksha Agarwal and Norenberg, {Michael D}",
year = "2017",
month = "2",
day = "1",
doi = "10.1111/jnc.13867",
language = "English (US)",
volume = "140",
pages = "645--661",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy

T2 - in vitro studies

AU - Jayakumar, Arumugam Radhakrishnan

AU - Tong, Xiao Y.

AU - Shamaladevi, Nagarajarao

AU - Barcelona, Stephanie

AU - Gaidosh, Gabriel

AU - Agarwal, Apeksha

AU - Norenberg, Michael D

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Transactivating DNA-binding protein-43 (TDP-43) inclusions and the accumulation of phosphorylated and ubiquitinated tau proteins (p-tau) have been identified in postmortem brain specimens from patients with chronic traumatic encephalopathy (CTE). To examine whether these proteins contribute to the development of CTE, we utilized an in vitro trauma system known to reproduce many of the findings observed in humans and experimental animals with traumatic brain injury. Accordingly, we examined the role of TDP-43 and Tau in an in vitro model of trauma, and determined whether these proteins contribute to the defective neuronal integrity associated with CNS trauma. Single or multiple episodes of trauma to cultured neurons resulted in a time-dependent increase in cytosolic levels of phosphorylated TDP-43 (p-TDP-43). Trauma to cultured neurons also caused an increase in levels of casein kinase 1 epsilon (CK1ε), and ubiquitinated p-TDP-43, along with a decrease in importin-β (all factors known to mediate the “TDP-43 proteinopathy”). Defective neuronal integrity, as evidenced by a reduction in levels of the NR1 subunit of the NMDA receptor, and in PSD95, along with increased levels of phosphorylated tau were also observed. Additionally, increased levels of intra- and extracellular thrombospondin-1 (TSP-1) (a factor known to regulate neuronal integrity) were observed in cultured astrocytes at early stages of trauma, while at later stages decreased levels were identified. The addition of recombinant TSP-1, conditioned media from cultured astrocytes at early stages of trauma, or the CK1ε inhibitor PF4800567 hydrochloride to traumatized cultured neurons reduced levels of p-TDP-43, and reversed the trauma-induced decline in NR1 subunit of the NMDA receptor and PSD95 levels. These findings suggest that a trauma-induced increase in TDP-43 phosphorylation contributes to defective neuronal integrity, and that increasing TSP-1 levels may represent a useful therapeutic approach for the prevention of the neuronal TDP-43 proteinopathy associated with CTE. (Figure presented.). Read the Editorial Highlight for this article on page 531.

AB - Transactivating DNA-binding protein-43 (TDP-43) inclusions and the accumulation of phosphorylated and ubiquitinated tau proteins (p-tau) have been identified in postmortem brain specimens from patients with chronic traumatic encephalopathy (CTE). To examine whether these proteins contribute to the development of CTE, we utilized an in vitro trauma system known to reproduce many of the findings observed in humans and experimental animals with traumatic brain injury. Accordingly, we examined the role of TDP-43 and Tau in an in vitro model of trauma, and determined whether these proteins contribute to the defective neuronal integrity associated with CNS trauma. Single or multiple episodes of trauma to cultured neurons resulted in a time-dependent increase in cytosolic levels of phosphorylated TDP-43 (p-TDP-43). Trauma to cultured neurons also caused an increase in levels of casein kinase 1 epsilon (CK1ε), and ubiquitinated p-TDP-43, along with a decrease in importin-β (all factors known to mediate the “TDP-43 proteinopathy”). Defective neuronal integrity, as evidenced by a reduction in levels of the NR1 subunit of the NMDA receptor, and in PSD95, along with increased levels of phosphorylated tau were also observed. Additionally, increased levels of intra- and extracellular thrombospondin-1 (TSP-1) (a factor known to regulate neuronal integrity) were observed in cultured astrocytes at early stages of trauma, while at later stages decreased levels were identified. The addition of recombinant TSP-1, conditioned media from cultured astrocytes at early stages of trauma, or the CK1ε inhibitor PF4800567 hydrochloride to traumatized cultured neurons reduced levels of p-TDP-43, and reversed the trauma-induced decline in NR1 subunit of the NMDA receptor and PSD95 levels. These findings suggest that a trauma-induced increase in TDP-43 phosphorylation contributes to defective neuronal integrity, and that increasing TSP-1 levels may represent a useful therapeutic approach for the prevention of the neuronal TDP-43 proteinopathy associated with CTE. (Figure presented.). Read the Editorial Highlight for this article on page 531.

KW - astrocytes

KW - chronic traumatic encephalopathy

KW - neurons

KW - p-tau

KW - TDP-43 proteinopathy

KW - thrombospondin-1

UR - http://www.scopus.com/inward/record.url?scp=85011857430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011857430&partnerID=8YFLogxK

U2 - 10.1111/jnc.13867

DO - 10.1111/jnc.13867

M3 - Article

VL - 140

SP - 645

EP - 661

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 4

ER -